Brief: Kiromic BioPharma Achieves Milestone With Timely Completion Of Expanded CGMP Manufacturing Facility To Support Cell Therapy Oncology Pipeline
07/07/2022 14:44
July 7 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA ACHIEVES MILESTONE WITH TIMELY
COMPLETION OF
EXPANDED CGMP MANUFACTURING FACILITY TO SUPPORT CELL THERAPY
ONCOLOGY PIPELINE
Source text for Eikon: ID:nBw9vd7NZa
Further company coverage: KRBP.O
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site